MED24 rs140397920: Understanding This Allergic Disorder Risk Locus
The genetic variant rs140397920 is a recently identified genomic marker located near the MED24 gene. Research suggests this variant may be associated with an increased susceptibility to allergic disorders.
What each genotype means
Typical risk profile
This genotype represents the most common form of this variant observed in the general population. Research into the MED24 region suggests that individuals with this profile do not carry the specific genetic marker associated with the studied allergic and inflammatory risk signals. This result should be interpreted in the context of your overall health history, as complex traits like asthma are influenced by many genetic and environmental factors.
This is the most frequent genotype found across all major global ancestral populations.
Increased risk marker
Carrying one copy of this variant has been identified in research as a potential risk locus for allergic disorders and inflammatory conditions. Because this variant is located in a gene cluster associated with immune response modulation, it may contribute to a higher statistical predisposition for conditions like asthma. This finding is based on population-level associations and does not indicate a diagnosis; please discuss your health history with a clinician.
This genotype is rare, appearing in a small percentage of the population across most ancestral groups.
Elevated risk marker
Carrying two copies of this variant is associated with the risk signal identified in studies of allergic and inflammatory disorders. While this variant is linked to the MED24 gene region and immune system regulation, the presence of this genotype is only one of many factors that influence individual health outcomes. This information is for educational purposes and should be discussed with a healthcare provider to understand its relevance to your personal health.
This genotype is very rare, observed at low frequencies in global population databases.
What is rs140397920?
The variant rs140397920 is a single nucleotide polymorphism (SNP) located on chromosome 17. In the context of human genetics, a SNP represents a variation at a single position in the DNA sequence among individuals. This specific variant was identified through a sophisticated statistical approach known as GWAS-by-Subtraction, which allows researchers to isolate genetic signals associated with specific traits that might otherwise be obscured in broader analyses. Because it is categorized as a rare variant, it is not found in the majority of the population. Its identification as a risk locus for allergic disorders is a relatively recent development in genomic science, marking it as a target for ongoing investigation into the complex genetic architecture that underlies immune system sensitivity and allergic responses.
The Role of the MED24 Gene
The variant rs140397920 is situated near the MED24 gene, which encodes the Mediator Complex Subunit 24. The Mediator complex is a large, multi-subunit protein assembly that plays a fundamental role in the regulation of gene expression. It acts as a molecular bridge, facilitating communication between various transcriptional activators and the cell's core machinery, specifically RNA polymerase II. By helping to initiate the transcription of DNA into RNA, the Mediator complex is essential for the proper functioning of many biological processes. Because it influences how genes are turned on or off, variations in or near genes like MED24 can potentially alter the expression levels of downstream targets, which may include genes involved in immune regulation and inflammatory pathways.
Research and Evidence Strength
The association between rs140397920 and allergic disorders is currently classified as having moderate evidence strength. This classification stems from its identification in recent studies utilizing genomic structural equation modeling, which highlighted this locus as a previously unreported contributor to the genetic risk of allergic conditions. While these findings are significant, it is important to note that the evidence is based on statistical associations observed in large-scale genomic datasets. In the field of complex disease genetics, a statistical association does not imply a direct cause-and-effect relationship. Further functional studies are required to determine exactly how this variant might influence biological pathways and whether it contributes directly to the development of allergic symptoms in clinical settings.
Population Frequency and Interpretation
Current data indicates that rs140397920 is a rare variant. In population genetics, 'rare' typically refers to variants that appear at a very low frequency across diverse ancestral groups. Because the variant is rare, it is not commonly encountered in the general population, and its specific impact may vary significantly depending on an individual's broader genetic background. It is essential to understand that possessing a risk-associated variant does not mean an individual will develop an allergic disorder. Allergic conditions are multifactorial, meaning they arise from a complex interplay between multiple genetic factors, environmental exposures, and lifestyle influences. Genetic markers like rs140397920 provide researchers with clues about biological mechanisms, but they are not diagnostic tools for predicting individual health outcomes.
What You Can Do With This Information
Information regarding genetic variants like rs140397920 is primarily intended for educational and research purposes. Because this variant is associated with complex traits rather than a single-gene disorder, it cannot be used to diagnose an allergy or predict your personal risk of developing one. If you have concerns about allergies, symptoms, or your family health history, the most effective approach is to consult with a qualified healthcare provider or an allergist. They can perform clinical evaluations, such as skin prick tests or blood tests, which are the standard methods for diagnosing allergic conditions. Never use genetic data to make decisions about your health, such as starting or stopping medications, without first discussing your specific situation with a medical professional who can interpret your results in the context of your overall health.
How common is this variant?
The variant rs140397920 is classified as rare, meaning the minor allele (G) occurs at a very low frequency across global populations.
Frequently asked questions
Does having the rs140397920 variant mean I have an allergy?
No. This variant is a statistical marker associated with a higher risk of allergic disorders in large population studies. It is not a diagnostic test, and many people with this variant do not have allergies.
Can I use this information to prevent allergies?
Currently, there are no clinical interventions or preventative measures based on this specific genetic variant. Allergic disorders are complex and influenced by many factors beyond genetics.
Where can I get tested for this variant?
This variant is typically identified through large-scale genomic research studies or comprehensive whole-genome sequencing. It is not part of standard clinical allergy testing.
Is the MED24 gene only involved in allergies?
No. The MED24 gene is part of the Mediator complex, which is involved in many fundamental cellular processes, including gene transcription. It has been studied in various contexts, including other inflammatory conditions.
Sources & further reading
Educational information only, last refreshed 10/12/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs140397920?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29